BSGM | Biosig stock plunges to lead Nasdaq losers after trial of COVID-19 treatment halted

Shares of Biosig Technologies Inc.plunged 39.0% in active morning trading Monday, enough to pace all Nasdaq decliners, after the medical technology company halted a trial of its COVID-19 treatment given disappointing results.Trading volume was 2.0 million shares, already nearly triple the full-day average of about 693,000 shares.The company’s oral merimepodib, in combination with intravenous remdesivir […]

BSGM | BioSig opts to shelve coronavirus trial of merimepodib in combination with remdesivir

BioSig Technologies Inc (NASDAQ:BSGM) and its subsidiary ViralClear Pharmaceuticals Inc have decided to halt its Phase 2 coronavirus trial of merimepodib paired with remdesivir, the company announced Monday.The study was expanded from 40 to 80 hospitalized COVID-19 patients, the company said, a decision that limited enrollment to NIAID Grade 3 participants, seriously ill patients who […]